加强自我管理对乙型肝炎肝硬化失代偿期患者恩替卡韦治疗依从性及疗效的影响

崔玉花; 魏小娟; 林慧美

doi:10.3969/j.issn.1001-5256.2014.10.019

加强自我管理对乙型肝炎肝硬化失代偿期患者恩替卡韦治疗依从性及疗效的影响

DOI: 10.3969/j.issn.1001-5256.2014.10.019

福建医科大学附属泉州市第一医院感染科

详细信息

中图分类号: R512.62;R575.2
计量
- 文章访问数: 2701
- HTML全文浏览量: 16
- PDF下载量: 577
- 被引次数: 0
出版历程
- 收稿日期: 2014-02-10
- 出版日期: 2014-10-20

Strengthening self-management improves treatment compliance and outcome in hepatitis B patients with decompensated cirrhosis treated with entecavir

Department of Infections Diseases, The First Hospital of Quanzhou Affiliated to Fujian Medical University

摘要

摘要: 目的探讨加强自我管理对乙型肝炎肝硬化失代偿期患者恩替卡韦抗病毒治疗的依从性及疗效的影响。方法选取2010年1月-2012年1月在福建医科大学附属泉州市第一医院住院使用恩替卡韦抗病毒治疗的乙型肝炎肝硬化失代偿期患者120例,随机分为对照组和干预组各60例。对照组实行常规护理,干预组在对照组基础上定期电话随访宣讲肝硬化失代偿期综合防治的自我管理指导。比较2组1年后停药率、再住院率、HBV DNA阴转率、原发性肝癌发生率和病死率。计量资料的比较采用t检验,计数资料的比较采用卡方检验或Fisher精确检验。结果干预组停药率和住院率分别为0和18.3%,对照组分别为8.3%和35.0%,2组比较差异有统计学意义（P值均<0.05）。干预组HBV DNA阴转率、原发性肝癌发生率和病死率分别为90.0%、3.3%、5.3%,对照组分别为88.3%、5%、6.7%,2组比较差异无统计学意义（P值均>0.05）。结论加强失代偿期乙型肝炎肝硬化恩替卡韦抗病毒治疗患者的自我管理,并对其经常性的健康宣教可以增加患者的依从性,有利于康复。
- 肝炎,乙型,慢性 /
- 肝硬化 /
- 自我遵嘱服药 /
- 恩替卡韦
Abstract: Objective To investigate the effect of strengthening self-management on the treatment compliance and outcome in hepatitis B patients with decompensated cirrhosis treated with entecavir. Methods A total of 120 hepatitis B patients with decompensated cirrhosis, who received antiviral therapy with entecavir in our hospital from January 2010 to January 2012, were randomly divided into control group ( n= 60) and intervention group ( n = 60) . Both groups received routine nursing care; in addition, regular telephone follow-up was performed for the intervention group to provide guidance for the self-management during the comprehensive prevention and treatment of decompensated cirrhosis. The two groups were compared in terms of withdrawal rate, rehospitalization rate, hepatitis B virus ( HBV) DNA negative conversion rate, incidence of primary liver cancer, and mortality one year later. Continuous data were analyzed by t test, and categorical data by chi-square test or Fisher's exact test. Results The withdrawal rate and rehospitalization rate in the intervention group were 0 and 18. 3%, respectively, versus 8. 3% and 35% in the control group ( P < 0. 05 for both) . The HBV DNA negative conversion rate, incidence of primary liver cancer, and mortality in the intervention group were 90%, 3. 3%, and 5. 3%, versus 88. 3%, 5%, and 6. 7% in the control group ( P >0.05 for all) . Conclusion Strengthening self-management, as well as regular health education, can improve treatment compliance and promote recovery in hepatitis B patients with decompensated cirrhosis treated with entecavir.
- hepatitis B, chronic /
- liver cirrhosis /
- self administration /
- entecavir

HTML全文

参考文献(11)

[1]de JONGH FE, JANSSEN HL, de MAN RA, et al.Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver[J].Gastroenterology, 1992, 103 (5) :1630-1635.

[2]HOSAKA T, SUZUKI F, KOBAYASHI M, et al.Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection[J].Hepatology, 2013, 58 (1) :98-107.

[3] Chinese Society of Hepatology, Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline for prevention and treatment of chronic hepatitis B[J].J Clin Hepatol, 2006, 22 (1) :3-15. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南[J].临床肝胆病杂志, 2006, 22 (1) :3-15.

[4]FAN JG, CAO HX.Prevention and treatment of complications of liver cirrhosis[J].Chin J Pract Intern Med, 2013, 33 (9) :673-675. (in Chinese) 范建高, 曹海霞.重视肝硬化并发症的预防和治疗[J].中国实用内科杂志, 2013, 33 (9) :673-675.

[5]HOU GY, WANG CX, YANG HR, et al.To observe the diet nursing care of patients with liver cirrhosis by hierarchical guidance[J].Hebei Med J, 2013, 35 (17) :2700-2701. (in Chinese) 侯桂英, 王晨雪, 杨会茹, 等.层级指导肝硬化患者饮食护理与观察[J].河北医药, 2013, 35 (17) :2700-2701.

[6]GOU W, WANG YL, XU XW, et al.Clinical efficacy of entecavir in treatment of hepatogenous diabetes[J].J Clin Hepatol, 2013, 29 (6) :456-458. (in Chinese) 苟卫, 王燕玲, 徐筱玮, 等.恩替卡韦治疗乙型肝炎肝硬化合并肝源性糖尿病的临床观察[J].临床肝胆病杂志, 2013, 29 (6) :456-458.

[7]ZHANG XH, LI ZP.Changes in serum complement components after 48 weeks of entecavir treatment in hepatitis B cirrhosis patients[J].J Clin Hepatol, 2013, 29 (5) :339-341. (in Chinese) 张雪华, 李仲平.恩替卡韦治疗乙型肝炎肝硬化患者48周前后血清补体的变化[J].临床肝胆病杂志, 2013, 29 (5) :339-341.

[8]European Association for the Study of the Liver.EASL clinical practice guidelines:management of chronic hepatitis B[J].J Hepatol, 2009, 50 (2) :227-242.

[9]REN YB, ZHANG H, SONG XY, et al.The effect of self-management education in patients with hepatitis C therapy by interferon[J].J Qilu Nurs, 2012, 18 (18) :19-20. (in Chinese) 任岳波, 张慧, 宋雪艾, 等.自我管理教育对行干扰素治疗丙型肝炎患者的影响[J].齐鲁护理杂志, 2012, 18 (18) :19-20.

[10]LI N, LAI EC, SHI J, et al.A comparative study of antiviral therapy after resection of hepatoellular carcinoma in the immune-active phase of hepatitis B virus infection[J].Ann Surg Oncol, 2012, 17 (1) :179-185.

[11]HUANG L, LI J, LAU WY, et al.Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma[J].J Gastroenterol Hepatol, 2012, 27 (1) :158-164.

施引文献

资源附件(0)

访问统计